Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Thursday, May 28, 2020
May 14 2020 - 4:26PM
Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical
technology company focused on the development and commercialization
of non-invasive medical devices to aid in the diagnosis of
respiratory sleep disorders, announced today that it will report
its unaudited financial results for the first quarter 2020 before
the U.S. market opens on Thursday, May 28, 2020.
The Company will host a conference call that day at
8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial
results and provide a corporate update. The call will be hosted by
Gilad Glick, President and CEO, and Shy Basson, CFO & US
COO.
To listen live via webcast, please
visit https://ir.itamar-medical.com/.
To participate via phone, please use the following
dial in information:U.S. toll-free: 877-407-8037 International:
201-689-8037 Israel toll-free: 1-809-406-247
Please log in approximately 10 minutes prior to the
scheduled start time. The archived webcast will be available in the
Events and Presentations section of the Company’s website for at
least 60 days following the call.
About Itamar Medical Ltd.Itamar
Medical is a medical technology company focused on the development
and commercialization of non-invasive medical devices to aid in the
diagnosis of respiratory sleep disorders. Itamar Medical
commercializes a digital healthcare platform to facilitate the
continuum of care for effective sleep apnea management with a focus
on the core sleep, cardiology and direct to consumer markets.
Itamar Medical offers a Total Sleep Solution to help physicians
provide comprehensive sleep apnea management in a variety of
clinical environments to optimize patient care and reduce
healthcare system costs. Itamar Medical is a public company traded
on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in
Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For
additional information visit www.itamar-medical.com.
Forward-Looking StatementsThis
press release contains forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995 and other applicable securities laws.
Statements preceded by, followed by, or that otherwise include the
words "believes", "expects", "anticipates", "intends", "estimates",
"plans", and similar expressions or future or conditional verbs
such as "will", "should", "would", "may" and "could" are generally
forward-looking in nature and not historical facts. Because such
statements deal with future events, they are subject to various
risks, uncertainties and assumptions, including events and
circumstances out of the Company's control and actual results,
expressed or implied by such forward-looking statements, could
differ materially from the Company's current expectations. Factors
that could cause or contribute to such differences include, but are
not limited to, risks, uncertainties and assumptions discussed from
time to time by the Company in reports filed with, or furnished to,
the U.S. Securities and Exchange Commission (“SEC”) and the Israel
Securities Authority (“ISA”), including the Company’s latest Form
20-F and its registration statement on Form F-1, which are each
accessible on the SEC’s website at www.sec.gov. Except as otherwise
required by law, the Company undertakes no obligation to publicly
release any revisions to these forward-looking statements to
reflect events or circumstances after the date hereof or to reflect
the occurrence of unanticipated events.
Itamar Medical Company
ContactItamar Medical Ltd.Shy BassonChief Financial
OfficerPhone: +972-4-617-7700bshy@itamar-medical.com
Itamar Medical Investor Relations Contact
(U.S.)Leigh Salvo or Caroline PaulGilmartin GroupPhone:
+1-415-937-5412investors@itamar-medical.com
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Apr 2023 to Apr 2024